{
  "ptid_time": "072_S_4063_2011-06-17",
  "img_path": "/data/qiuhui/data/adni/images/072_S_4063/2011-06-17/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 6,621 mm³, 64.4% below the reference mean. With a Z-score of -1.84 (3.3th percentile), this represents moderate atrophy; hippocampal volume measures 7,122 mm³, 8.8% below the reference mean. With a Z-score of -1.22 (11.1th percentile), this represents mild atrophy; whole brain volume measures 921,958 mm³, 11.4% below the reference mean. With a Z-score of -1.37 (8.6th percentile), this represents mild atrophy; entorhinal cortex volume measures 3,185 mm³, 13.8% below the reference mean. With a Z-score of -1.08 (14.0th percentile), this represents mild atrophy; fusiform gyrus volume measures 16,579 mm³, 10.1% below the reference mean. With a Z-score of -0.91 (18.1th percentile), this represents normal volume ; middle temporal gyrus volume measures 16,494 mm³, 19.7% below the reference mean. With a Z-score of -1.62 (5.2th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 59.2 years. Gender is Female. Education: 13 years. Handedness: Right. Race: White. Medical history: Psychiatric; Neurologic; Respiratory; Dermatologic-Connective Tissue; Musculoskeletal; Gastrointestinal; Renal-Genitourinary; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 30.0. MoCA: 25.0. Logical Memory: 8.0. Laboratory findings: ALT (SGPT): 52.00 (profound elevated); AST (SGOT): 46.00 (profound elevated). APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.01 SUVR (normal ); Total tau: 201.90 pg/mL (normal ); Phosphorylated tau: 19.23 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data show moderate atrophy in the ventricles and middle temporal gyrus, with mild atrophy in the hippocampus, whole brain, and entorhinal cortex. Despite these structural changes, cognitive testing (MMSE 30, MoCA 25) is within normal limits, and biomarkers (T-tau, P-tau, AV45) are normal. The absence of significant cognitive decline suggests early neurodegeneration without functional impairment.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (due to structural atrophy without overt cognitive deficits, but biomarker and APOE4 status do not strongly support AD pathology).",
  "timestamp": "2025-07-26T09:16:14.211185"
}